Funding · Company
Avenacy Inc.
Schaumburg, ILBiotech & Pharma
Avenacy Inc. of Schaumburg, IL has disclosed $26M across 1 Form D offering filed with the SEC on Nov 26, 2024.
$26M
Total disclosed
1
Form D offering
2023
Incorporated
Offerings on file
Each amount is as reported on that filing, cumulative across its own amendments. Newest first.
$26M
Form D · Nov 26, 2024 ↗
Q4 2024
· target $34M
Filing details
HeadquartersSchaumburg, ILIndustryBiotech & Pharma (Pharmaceuticals)Incorporated2023SEC CIK0002046254Offerings on file1
Source: SEC Form D structured data. Amounts are self-reported by the issuer on a notice filing — not audited, and cumulative across amendments. The website link is resolved automatically and may be wrong — tell us if it is. Full methodology →